Literature DB >> 15339046

Role of subtilisin-like convertases in cadherin processing or the conundrum to stall cadherin function by convertase inhibitors in cancer therapy.

E J Müller1, R Caldelari, H Posthaus.   

Abstract

Cadherins are a family of intercellular adhesion receptors. Produced as inactive precursors, they become functional adhesion molecules after proteolytic cleavage by subtilisin-like pro-protein convertases (PCs). Owing to their activation and assembly into multiprotein adhesion complexes at sites of cell contacts, adhesion-competent cadherins are prerequisite for tissue integrity. In recent years evidence has accumulated that intercellular junctions not only provide mechanical linkage, but in addition are potent modulators of signalling cascades. This infers a biological role to intercellular adhesion complexes that is significantly more complex and powerful. Currently, the broad implications of disturbances in somatic tissue adhesion components are only just beginning to emerge. Prominent examples of adhesion defects include autoimmune diseases, or tumour invasion and metastasis and malignant transformation. This review reports on our current knowledge of cadherin function and their maturation by pro-protein convertases, and puts special emphasis on the consequences of pro-protein convertase inhibition for epithelial tissue homeostasis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15339046     DOI: 10.1023/b:hijo.0000032358.51866.a2

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  148 in total

1.  Targeting of p0071 to desmosomes and adherens junctions is mediated by different protein domains.

Authors:  Mechthild Hatzfeld; Kathleen J Green; Helmut Sauter
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

2.  Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role.

Authors:  K Vleminckx; L Vakaet; M Mareel; W Fiers; F van Roy
Journal:  Cell       Date:  1991-07-12       Impact factor: 41.582

3.  Furin is a subtilisin-like proprotein processing enzyme in higher eukaryotes.

Authors:  W J van de Ven; J Voorberg; R Fontijn; H Pannekoek; A M van den Ouweland; H L van Duijnhoven; A J Roebroek; R J Siezen
Journal:  Mol Biol Rep       Date:  1990-11       Impact factor: 2.316

4.  Localization of prohormone convertases 1/3 and 2 in the human pituitary gland and pituitary adenomas: analysis by immunohistochemistry, immunoelectron microscopy, and laser scanning microscopy.

Authors:  I Takumi; D F Steiner; N Sanno; A Teramoto; R Y Osamura
Journal:  Mod Pathol       Date:  1998-03       Impact factor: 7.842

5.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

6.  Haploinsufficiency of desmoplakin causes a striate subtype of palmoplantar keratoderma.

Authors:  D K Armstrong; K E McKenna; P E Purkis; K J Green; R A Eady; I M Leigh; A E Hughes
Journal:  Hum Mol Genet       Date:  1999-01       Impact factor: 6.150

Review 7.  Caught up in a Wnt storm: Wnt signaling in cancer.

Authors:  Rachel H Giles; Johan H van Es; Hans Clevers
Journal:  Biochim Biophys Acta       Date:  2003-06-05

8.  E-Cadherin mediates MMP down-regulation in highly invasive bronchial tumor cells.

Authors:  Béatrice Nawrocki-Raby; Christine Gilles; Myriam Polette; Corinne Martinella-Catusse; Noël Bonnet; Edith Puchelle; Jean-Michel Foidart; Frans Van Roy; Philippe Birembaut
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

9.  Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis.

Authors:  Maralice E Conacci-Sorrell; Tamar Ben-Yedidia; Michael Shtutman; Elena Feinstein; Paz Einat; Avri Ben-Ze'ev
Journal:  Genes Dev       Date:  2002-08-15       Impact factor: 11.361

10.  Comparative analysis of expression of the proprotein convertases furin, PACE4, PC1 and PC2 in human lung tumours.

Authors:  M Mbikay; F Sirois; J Yao; N G Seidah; M Chrétien
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more
  6 in total

Review 1.  Intercellular junction assembly, dynamics, and homeostasis.

Authors:  Kathleen J Green; Spiro Getsios; Sergey Troyanovsky; L M Godsel
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

Review 2.  Peptide processing and biology in human disease.

Authors:  Suzana Kovac; Arthur Shulkes; Graham S Baldwin
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-02       Impact factor: 3.243

3.  Pro-protein convertase-2/carboxypeptidase-E mediated neuropeptide processing of RGC-5 cell after in vitro ischemia.

Authors:  Song-Shan Tang; Juan-Hui Zhang; Huan-Xin Liu; Dong Zhou; Rong Qi
Journal:  Neurosci Bull       Date:  2009-02       Impact factor: 5.203

4.  Potent inhibitors of furin and furin-like proprotein convertases containing decarboxylated P1 arginine mimetics.

Authors:  Gero L Becker; Frank Sielaff; Manuel E Than; Iris Lindberg; Sophie Routhier; Robert Day; Yinghui Lu; Wolfgang Garten; Torsten Steinmetzer
Journal:  J Med Chem       Date:  2010-02-11       Impact factor: 7.446

5.  PC2/CPE-mediated pro-protein processing in tumor cells and its differentiated cells or tissues.

Authors:  Song-Shan Tang; Juan-Hui Zhang; Huan-Xin Liu; Hong-Zhi Li
Journal:  Mol Cell Endocrinol       Date:  2009-02-07       Impact factor: 4.102

Review 6.  Potential opportunity in the development of new therapeutic agents based on endogenous and exogenous inhibitors of the proprotein convertases.

Authors:  Yannick Bontemps; Nathalie Scamuffa; Fabien Calvo; Abdel-Majid Khatib
Journal:  Med Res Rev       Date:  2007-09       Impact factor: 12.944

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.